Geoffrey Beran Rose

Geoffrey Beran Rose

Chief Commercial OfficeratPulmonx· In proxies 2022–2023

Pay in FY2023-11% from the year before · Pulmonx stock +51.2% the same year

Geoffrey Beran Rose was paid $2.0M in FY2023 (Dec), down 11%. Pulmonx stock rose 51.2% that year.

Pay$100 in the stock at the end of FY21 → $40
Pay is from the Summary Compensation Table of each Pulmonx proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PulmonxPublic company · 4 yr
    • Chief Commercial Officer2022 – Present · 4 yrStock in role -92%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?